Neogenomics (NEO) Change in Inventory (2010 - 2026)

Neogenomics has reported Change in Inventory for 17 years, with the latest figure at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 57.97% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at -$210000.0 (down 102.2% YoY), and the FY2025 full-year result was $1.5 million, down 42.83% from the prior year.
• Change in Inventory for Q1 2026 stood at $1.3 million, up from $28000.0 in the prior quarter.
• The five-year high for Change in Inventory was $4.1 million in Q2 2025, with the low at -$5.6 million in Q3 2025.
• Historically, Change in Inventory has averaged $415705.9 across 5 years, with a median of $688000.0 in 2023.
• The largest YoY upside for Change in Inventory was 1034.16% in 2024 against a maximum downside of 2018.0% in 2024.
• Neogenomics' Change in Inventory stood at $697000.0 in 2022, then tumbled by 71.02% to $202000.0 in 2023, then soared by 1034.16% to $2.3 million in 2024, then tumbled by 98.78% to $28000.0 in 2025, then soared by 4439.29% to $1.3 million in 2026.
• The last three Change in Inventory figures came in at $1.3 million (Q1 2026), $28000.0 (Q4 2025), and -$5.6 million (Q3 2025), per Business Quant data.